Evidence map›Paper›PMID 32003755›Full record

ArticleAging2020

The neuroprotective effects of SIRT1 in mice carrying the APP/PS1 double-transgenic mutation and in SH-SY5Y cells over-expressing human APP670/671 may involve elevated levels of α7 nicotinic acetylcholine receptors.

Kun Cao, Yang-Ting Dong, Jie Xiang, Yi Xu, Yi Li, Hui Song, Wen-Feng Yu, Xiao-Lan Qi, Zhi-Zhong Guan

Open access · greenAbstract read
In one paragraph

Article in Aging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. The Beneficial Roles of SIRT1 in Neuroinflammation-Related Diseases.Oxidative medicine and cellular longevity · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Kun CaoDepartment of Pathology at Guizhou Medical University and Pathology Department in Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, P. R. of China.
Yang-Ting DongKey Laboratory of Endemic and Ethnic Diseases of the Ministry of Education of P. R. China (Guizhou Medical University), Guiyang, Guizhou, P. R. of China.
Jie XiangDepartment of Pathology at Guizhou Medical University and Pathology Department in Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, P. R. of China.
Yi XuDepartment of Pathology at Guizhou Medical University and Pathology Department in Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, P. R. of China.
Yi LiKey Laboratory of Endemic and Ethnic Diseases of the Ministry of Education of P. R. China (Guizhou Medical University), Guiyang, Guizhou, P. R. of China.
Hui SongKey Laboratory of Endemic and Ethnic Diseases of the Ministry of Education of P. R. China (Guizhou Medical University), Guiyang, Guizhou, P. R. of China.
Wen-Feng YuKey Laboratory of Endemic and Ethnic Diseases of the Ministry of Education of P. R. China (Guizhou Medical University), Guiyang, Guizhou, P. R. of China.
Xiao-Lan QiKey Laboratory of Endemic and Ethnic Diseases of the Ministry of Education of P. R. China (Guizhou Medical University), Guiyang, Guizhou, P. R. of China.
Zhi-Zhong GuanDepartment of Pathology at Guizhou Medical University and Pathology Department in Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, P. R. of China.
Guiyang Medical University · CNAffiliated Hospital of Guizhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim was to determine whether the neuroprotective effect of SIRT1 in Alzheimer's disease (AD), due to inhibition of aggregation of the β-amyloid peptide (Aβ), involves activation of α7 nAChR. In present study, four-month-old APP/PS1 mice were administered resveratrol (RSV) or suramin once daily for two months, following which their spatial learning and memory were assessed using the Morris water maze test. Deposits of Aβ in vivo were detected by near-infrared imaging (NIRI) and confocal laser scanning. SH-SY5Y/APP

Indexed as

Gene ExpressionMutationalpha7 Nicotinic Acetylcholine ReceptorAmyloid beta-Protein PrecursorAnimalsBiomarkersCell Line, TumorHumansMAP Kinase Signaling SystemMemoryMiceMice, TransgenicNeuronsNeuroprotectionRNA InterferenceSirtuin 1alpha7 Nicotinic Acetylcholine ReceptorAmyloid beta-Protein PrecursorBiomarkersSirt1 protein, mouseSirtuin 1SuraminAlzheimer’s diseaseAPP/PS1 miceMAPKSIRT1α7 nAChR

Identifiers

PMID32003755
PMCPMC7053601
OpenAlexW3004364079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.